References
- CikrikciogluMAHalacGHursitogluMPrevalence of gluten sensitive enteropathy antibodies in restless legs syndromeActa Neurol Belg2011111428228622368967
- HoglBKiechlSWilleitJRestless legs syndrome: a community-based study of prevalence, severity, and risk factorsNeurology2005641920192415955944
- AllenRDopamine and iron in the pathophysiology of restless legs syndromeSleep Med20045438539115222997
- BaskolGKorkmazSErdemFAssessment of nitricoxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndromeSleep Med20121341441822469072
- InnesKESelfeTKAgarwalPRestless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic reviewSleep Med Rev20121630933921733722
- WaltersAERyeDBReview of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and strokeSleep200932558959719480225
- UlfbergJNystromBCarterNPrevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptomsMov Disord2001161159116311748753
- OhayonMMRothTPrevalence of restless legs syndrome and periodic limb movement disorder in the general populationJ Psychosom Res20025354755412127170
- WinkelmanJWFinnLYoungTPrevalence and correlates of restless legs syndrome symptoms in the Wisconsin sleep cohortSleep Med2006754555216740407
- LiYWaltersASChiuveSEProspective study of restless legs syndrome and coronary heart disease among womenCirculation20121261689169422967852
- ElwoodPHackMPickeringJHughesJGallacherJSleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohortJ Epidemiol Community Health200660696073
- WinterACSchürksMGlynnRJRestless legs syndrome and risk of incident cardiovascular disease in woman and men; prospective cohort studyBMJ Open20122e000866
- WinterACSchürksMGlynnRJVascular risk factors, cardiovascular disease and restless legs syndrome in womenAm J Med20131263220227623410562
- BenediktsdottirBJansonCLindbergEPrevalence of restless legs syndrome among adults in Iceland and Sweden: lung function, comorbidity, ferritin, biomarkers and quality of lifeSleep Med2010111043104820961808
- ParkJHHanSWBaikJSCarotid intima-media thickness in patients with idiopathic restless legs syndromeEur Neurol201267632132522555556
- Q-JacoboKMongeAOrtiz-PanozoEAbstract P074: restless legs syndrome and carotid intima-media thickness in women circulationSleep2015131
- AfsarBTakirMKostekOCovicAKanbayMEndocan: a new molecule playing a role in the development of hypertension and chronic kidney disease?J Clin Hypertens (Greenwich)2014161291491610.1111/jch.1244025376269
- KaliAShettyKSEndocan: a novel circulating proteoglycanIndian J Pharmacol201446657958310.4103/0253-7613.14489125538326
- CelıkTBaltaSKaramanMEndocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartanBlood Press2015241556010.3109/08037051.2014.97281625390761
- WangXSYangWLuoTWangJMJingYYSerum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertensionGenet Test Mol Biomarkers201519312412710.1089/gtmb.2014.027425588082
- ArmanYAkpinarTSEffect of glycemic regulation on endocan levels in patients with diabetes: a preliminary studyAngiology2015pii0003319715585664 Epub ahead of print25969567
- OndoWGRestless legs syndromeNeurol Clin2009273779799vii19555831
- WaltersASLeBrocqCDharAValidation of the international restless legs syndrome study group rating scale for restless legs syndrome; International Restless Legs Syndrome Study GroupSleep Med20034212113214592342
- AllenRPEarleyCJValidation of the Johns Hopkins restless legs severity scaleSleep Med20012323924211311687
- CikrikciogluMAHursitogluMErkalHOxidative stress and autonomic nervous system functions in restless legs syndromeEur J Clin Invest201141773474210.1111/j.1365-2362.2010.02461.x21250984
- PéronnetFClerouxJPerraultHPlasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in manMed Sci Sports Exerc19851766836884079740
- MönnikesHKoopHEhlenzKDionysiusJArnoldRRole of circulating catecholamines in the control of pancreatic polypeptide and gastrin releaseRes Exp Med (Berl)198918931811872749007
- HornyakMRuppARiemannDFeigeBBergerMVoderholzerULow-dose hydrocortisone in the evening modulates symptom severity in restless legs syndromeNeurology200870181620162218443313
- SchillingCSchredlMStroblPDeuschleMRestless legs syndrome: evidence for nocturnal hypothalamic–pituitary–adrenal system activationMov Disord20102581047105220535825
- LambertEATeedeHSariCISympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistanceClin Endocrinol (Oxf)201510.1111/cen.12803 Epub ahead of print
- BalkayaMPrinzVCustodisFStress worsens endothelial function and ischemic stroke via glucocorticoidsStroke201142113258326421921276
- ChandranDSJaryalAKJyotsnaVPDeepakKKImpaired endothelium mediated vascular reactivity in endogenous Cushing’s syndromeEndocrinol J2011589789799
- BeckDTCaseyDPMartinJSEmersonBDBraithRWExercise training improves endothelial function in young prehypertensivesExp Biol Med (Maywood)2013238443344110.1177/153537021347760023760009
- SprungVSCuthbertsonDJPughCJNitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary syndrome but can be improved by exercise trainingJ Physiol2013591Pt 61475148710.1113/jphysiol.2012.24691823318877
- Wahlin-LarssonBWKadiFUlfbergJAulinKPSkeletal muscle morphology in patients with restless legs syndromeEur Neurol20075813313717622717
- BostantjopoulouSKatsarouZFrangiaTEndothelial function markers in parkinsonian patients with hyperhomocysteinemiaJ Clin Neurosci200512666967216040247
- NakasoKYasuiKKowaHHypertrophy of IMC of carotid artery in Parkinson’s disease is associated with L-DOPA, homocysteine, and MTHFR genotypeJ Neurol Sci2003207192312614926
- YilmazMISiriopolDSaglamMPlasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney diseaseKidney Int20148661213122024988065